Categories: News

Zynex to Present at the Spring Investor Summit on April 2nd in New York City at the Essex House

ENGLEWOOD, CO / ACCESSWIRE / March 26, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that Thomas Sandgaard, Chief Executive Officer of Zynex will be presenting at this year’s Spring Investor Summit on Tuesday April, 2, 2019 at 2:00 pm EDT in New York City.

Management will also be meeting with members of the investment community during one-on-one meetings.

Event: Spring Investor Summit

Date: Tuesday April 2, 2019

Time: 2:00 pm (Eastern Time)

Location: Essex House – Track 1

A live audio webcast of the presentation will be available using the following link:

https://www.webcaster4.com/Webcast/Page/2038/29986

It will also be available on the investor relations section of the company website at www.zynex.com. A replay of the presentation will be available for 1 year.

CONFERENCE OVERVIEW AND STRUCTURE

The Spring Investor Summit (formerly The MicroCap Conference) is an exclusive event dedicated to connecting small and micro cap companies with high-level, institutional and retail investors.

The Spring Investor Summit will take place in New York City at the Essex House on April 1st and 2nd. The upcoming conference will feature 200 presenting companies, 1200 institutional and retail investors, 2000 one-on-one meetings, expert speakers, and industry panels.

REGISTRATION FOR INVESTORS

To request free registration, please go to our website (www.springinvestorsummit.com), and click the “Registration” button.

PARTICIPATING COMPANIES

For our most updated list of companies, please go to our website (www.springinvestorsummit.com).

ABOUT ZYNEX

Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company’s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: Zynex.com.

ZYNEX INVESTOR RELATIONS CONTACT:

Amato and Partners, LLC
100 Park Avenue, 16th Floor
New York, NY 10017
(212) 430-0360
admin@amatoandpartners.com

FOR MORE INFORMATION:

Please visit: www.springinvestorsummit.com
Or, contact Ashley Allard at ashley@microcapconf.com

News Compliments of ACCESSWIRE

SOURCE: Zynex, Inc.

View source version on accesswire.com:
https://www.accesswire.com/540108/Zynex-to-Present-at-the-Spring-Investor-Summit-on-April-2nd-in-New-York-City-at-the-Essex-House

user

Recent Posts

Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani

* Efficacy, safety, and cost-effectiveness of Thermobalancing therapy and Dr Allen's Devices were showcased at…

11 hours ago

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: investorrelations@financiere-tubize.be Annual Report…

1 day ago

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP…

1 day ago

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and…

1 day ago

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

1 day ago

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX)…

1 day ago